Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6744326 | 0.86 | GBA1 (0.32) | CYP3A4 | |
| SCHEMBL18335379 | 0.86 | GBA1 (0.32) | CYP3A4 | |
| SCHEMBL18335397 | 0.86 | CYP3A4 (0.30) | CYP3A4 | |
| SCHEMBL18335378 | 0.84 | GBA1 (0.35) | — | |
| SCHEMBL13528521 | 0.82 | SLC2A1 (0.33) | ALDH1A1CYP3A4 | |
| SCHEMBL17131873 | 0.82 | SLC2A1 (0.33) | ALDH1A1CYP3A4 | |
| SCHEMBL18335407 | 0.80 | GBA1 (0.37) | CYP3A4 | |
| SCHEMBL4374229 | 0.80 | SLC2A1 (0.33) | CYP3A4 | |
| SCHEMBL14000857 | 0.78 | GBA1 (0.41) | ALDH1A1 | |
| SCHEMBL15326549 | 0.78 | GBA1 (0.41) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143362-B2 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-03-27 | — | — | US | claimed |
| US-20100331444-A1 | COMPOSITION CONTAINING UNSATURATED SILICONE COMPOUNDS, DENTAL MATERIALS CONTAINING THEM AND USE THEREOF | 3M ESPE AG (A WHOLLY-OWNED SUBSIDUARY OF 3M COMPANY) | 2010-12-30 | — | — | US | claimed |
| US-7807730-B2 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M ESPE AG (DE) | 2010-10-05 | — | — | US | claimed |
| EP-1650263-B1 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | MINNESOTA MINING MFG GMBH (DE) | 2013-10-23 | — | — | EP | disclosed |
| US-8143362-B2 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| US-20100331444-A1 | COMPOSITION CONTAINING UNSATURATED SILICONE COMPOUNDS, DENTAL MATERIALS CONTAINING THEM AND USE THEREOF | 3M ESPE AG (A WHOLLY-OWNED SUBSIDUARY OF 3M COMPANY) | 2010-12-30 | — | — | US | disclosed |
| US-7807730-B2 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M ESPE AG (DE) | 2010-10-05 | — | — | US | disclosed |
| US-7648985-B2 | Oxabispidine compounds and their use in the treatment of cardiac arrhythmias | ASTRAZENECA AB (SE) | 2010-01-19 | — | — | US | disclosed |
| US-20090270383-A1 | Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias | ASTRAZENECA AB (SE) | 2009-10-29 | — | — | US | disclosed |
| US-20090005558-A1 | Novel Oxabispidine Compounds and Their Use in the Treatment of Cardiac Arrhythmias | ASTRAZENECA AB (SE) | 2009-01-01 | — | — | US | disclosed |
| EP-1765832-A1 | NOVEL OXABISPIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CARDIAC ARRHYTHMIAS | AstraZeneca AB (SE) | 2007-03-28 | — | — | EP | disclosed |
| US-20060111464-A1 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M DEUTSCHLAND GMBH (DE) | 2006-05-25 | — | — | US | disclosed |
| EP-1652889-A1 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M Espe AG (DE) | 2006-05-03 | — | — | EP | disclosed |
| EP-1650263-A1 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | 3M Espe AG (DE) | 2006-04-26 | — | — | EP | disclosed |
| WO-2005123748-A1 | NOVEL OXABISPIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CARDIAC ARRHYTHMIAS | ASTRAZENECA AB (SE) | 2005-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270383-A1 | Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias | KCNH1, RYR1, CACNA1E | ALDH1A1 468/4885CYP3A4 725/4885 |
| US-20100331444-A1 | COMPOSITION CONTAINING UNSATURATED SILICONE COMPOUNDS, DENTAL MATERIALS CONTAINING THEM AND USE THEREOF | SMCHD1, CAD, ESD | ALDH1A1 1550/4885CYP3A4 2994/4885 |
| US-20060111464-A1 | Composition containing unsaturated silicone compounds, dental materials containing them and use thereof | CAD, SMCHD1, SUPT16H | ALDH1A1 2624/4885CYP3A4 2982/4885 |
| US-20090005558-A1 | Novel Oxabispidine Compounds and Their Use in the Treatment of Cardiac Arrhythmias | KCNH1, RYR1, CACNA1E | ALDH1A1 468/4885CYP3A4 725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.